Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. It is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.
公司代碼CODX
公司名稱Co-Diagnostics Inc
上市日期Jul 12, 2017
CEOEgan (Dwight H)
員工數量132
證券類型Ordinary Share
年結日Jul 12
公司地址2401 S. Foothill Dr. Suite D
城市SALT LAKE CITY
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編84109
電話18014381036
網址https://codiagnostics.com/
公司代碼CODX
上市日期Jul 12, 2017
CEOEgan (Dwight H)